Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04512287 · ClinicalTrials.gov registry record · Phase 2
PRP for Treatment of Peyronie's Disease
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT04512287 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 65 participants.
The verdict
NCT04512287, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the effects of Platelet-Rich Plasma (PRP) injection in men with Peyronie's Disease (PyD).
Interventions
- OTHER Saline Solution
- DRUG Autologous Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2025-08-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04512287
The ClinicalTrials.gov registry entry for NCT04512287 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Solution is the first listed.
NCT04512287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04512287 about?
NCT04512287 is a clinical study titled "PRP for Treatment of Peyronie's Disease". The purpose of this study is to learn about the effects of Platelet-Rich Plasma (PRP) injection in men with Peyronie's Disease (PyD).
What is the current status of trial NCT04512287?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2021-03-29. Estimated completion is 2025-08-11.
What interventions are being tested in trial NCT04512287?
The interventions under investigation include: Saline Solution (OTHER), Autologous Platelet Rich Plasma (DRUG).
Who is sponsoring clinical trial NCT04512287?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.